Biotech raising $35 million to take a second stab at cancer drug from Bert Vogelstein’s lab Cage Pharma sees promise in the therapy despite a troubled history

https://www.statnews.com/2025/03/13/biotech-cage-pharma-bert-vogelstein-cancer-research/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-_JW-mxNlZhYA01dxFXDYC--LnqG3HXHH_z9L4_GilpwlarMKJSP13vctXOFb2Ad99FRRt5FwfdYFtXkdfMINmcDd3Q5g&_hsmi=351825926&utm_content=351825926&utm_source=hs_email